Epidemiological aspects of cardiometabolic risk by HASH(0x7fe990801648)
EPIDEMIOLOGICAL ASPECTS OF 
CARDIOMETABOLIC RISK 
 
 
Ph.D. Thesis 
Doctoral School of Interdisciplinary Medicine 
University of Szeged 
 
 
Ádám Hulmán, M.Sc. 
Department of Medical Physics and Informatics 
University of Szeged 
 
 
Supervisors 
Daniel R. Witte, M.D., Ph.D. 
Centre de Recherche Public de la Santé, Luxembourg 
János Karsai, Ph.D. 
Bolyai Institute, University of Szeged 
Tibor Nyári, Ph.D. 
Department of Medical Physics and Informatics, University of Szeged 
 
 
Szeged, 2014
	   1 
TABLE OF CONTENTS 
1 Introduction ..................................................................................................................... 5 
1.1 Maternal obesity and gestational weight gain .......................................................... 7 
1.2 Secular trends and age-related trajectories of risk factors ........................................ 8 
1.3 Diurnal variation of glucose measures ..................................................................... 9 
2 Aims .............................................................................................................................. 10 
3 Methods – General overview ........................................................................................ 11 
3.1 Quantile regression ................................................................................................. 11 
3.2 Mixed-effects models ............................................................................................. 12 
4 Methods - Specific study settings and analyses ............................................................ 15 
4.1 Maternal obesity and gestational weight gain ........................................................ 15 
4.1.1 Gestational diabetes screening at the Szent Imre Hospital, Budapest ............. 15 
4.1.2 Distributional associations of maternal obesity and birthweight .................... 15 
4.1.3 Evaluation of hypothetical prevention strategies ............................................ 16 
4.2 Secular trends and age-related trajectories of risk factors ...................................... 16 
4.2.1 The Whitehall II study ..................................................................................... 16 
4.2.2 Sequential cross-sectional analysis ................................................................. 18 
4.2.3 Longitudinal analysis ...................................................................................... 18 
4.3 Diurnal variation of glucose measures ................................................................... 19 
4.3.1 Glucose measures in the Whitehall II study .................................................... 19 
4.3.2 Association between fasting status, time of OGTT and glucose measures ..... 19 
5 Results ........................................................................................................................... 21 
5.1 Maternal obesity and gestational weight gain ........................................................ 21 
5.2 Secular trends and age-related trajectories of risk factors ...................................... 23 
5.2.1 Distributional trends (age group: 57-61 years) ............................................... 23 
5.2.2 Age-related trajectories ................................................................................... 27 
5.3 Diurnal variation of glucose measures ................................................................... 29 
6 Discussion ..................................................................................................................... 32 
6.1 Maternal obesity and gestational weight gain ........................................................ 32 
6.1.1 Geoffrey Rose’s population approach ............................................................. 32 
6.1.2 Targeted interventions ..................................................................................... 33 
6.1.3 Public health implications ............................................................................... 33 
	   2 
6.1.4 Strengths and limitations ................................................................................. 34 
6.2 Secular trends and age-related trajectories of risk factors ...................................... 34 
6.2.1 Obesity ............................................................................................................ 34 
6.2.2 Blood pressure ................................................................................................. 36 
6.2.3 Cholesterol ...................................................................................................... 37 
6.2.4 Strengths and limitations ................................................................................. 38 
6.3 Diurnal variation of glucose measures ................................................................... 38 
6.3.1 Diabetes diagnosis ........................................................................................... 38 
6.3.2 Fasting glucose ................................................................................................ 39 
6.3.3 Glucose tolerance (2hPG) ............................................................................... 39 
6.3.4 HbA1c ............................................................................................................... 39 
6.3.5 Strengths and limitations ................................................................................. 40 
7 Summary and Conclusions ............................................................................................ 41 
8 Acknowledgements ....................................................................................................... 44 
9 References ..................................................................................................................... 45 	    
	   3 
GLOSSARY OF ABBREVIATIONS 
2hPG 2-hour post-load plasma glucose 
ADA American Diabetes Association 
BMI Body mass index 
CI Confidence interval 
CVD Cardiovascular disease 
DBP Diastolic blood pressure 
FD Fasting duration 
FPG Fasting plasma glucose 
GDM Gestational diabetes mellitus 
GWG Gestational weight gain 
HbA1c Glycated hemoglobin 
HDL High-density lipoprotein 
IOM Institute of Medicine 
LGA Large for gestational age 
MAR Missing at random 
MCAR Missing completely at random 
MNAR Missing not at random 
NCD Non-communicable disease 
OLS Ordinary least squares 
SBP Systolic blood pressure 
SGA Small for gestational age 
OGTT Oral glucose tolerance test 
 
TC Total cholesterol 
TD Time of day 
WC Waist circumference 
WHO World Health Organization 
YB Year of birth 
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1 INTRODUCTION 
During the second half of the last century, the main focus of epidemiology turned 
from infectious to non-communicable disease (NCD). According to a WHO report [1], 
NCD was responsible for 63% of the 57 million deaths which occurred globally in 2008. 
The leading cause among NCD deaths was cardiovascular disease (CVD) with 17 million 
cases (48%), followed by cancer (7.6 million, 21%), chronic respiratory disease (4.2 
million, 12%) and diabetes with an additional 1.3 million deaths (4%). Beside premature 
deaths, morbidity that affects quality of life is also a major component of the burden of 
NCD. The prevalence of diabetes was about 10% in 2008 among adults over 25 years of 
age. People with diabetes have a two- to fourfold risk of CVD compared to those without 
diabetes. In addition, diabetes is also a leading cause of renal failure, visual impairment 
and non-traumatic lower limb amputation. The global economic effects of diabetes are also 
significant. People with diabetes need approximately three times the health-care resources 
compared to those without diabetes, which added up to 12% of total health expenditures in 
2010 [2].  
Overall cardiometabolic risk is determined by various risk factors which play a key 
role in the pathophysiology which leads to CVD and type 2 diabetes (Figure 1). The four 
most important modifiable behavioural risk factors include tobacco smoking, sedentary 
lifestyle, unhealthy diet and excessive alcohol consumption. These lifestyle patterns result 
in adverse changes in metabolic risk factors, such as obesity, hypertension, 
hyperglycaemia and dyslipidemia. Non-modifiable risk factors include race, ethnicity, sex, 
age and family history of diseases. Analysis of cross-sectional data is not sufficient to 
investigate causality between risk factors and diseases, which points out the importance of 
prospective studies. The Framingham Heart Study was the first large longitudinal study 
(initiated in 1948) investigating characteristics of risk factors that lead to CVD. The study 
played an important role in the identification of risk factors [3]. However, secular trends 
and changes in diagnostic criteria make it a challenging task to adequately utilize data 
collected during a long period. 
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Figure 1 Factors contributing to cardiometabolic risk (source: ADA, CMR Graphica) 
In 2011, the Global Burden of Metabolic Risk Factors of Chronic Diseases 
Collaborating Group published four reports in the Lancet on global trends of body mass 
index (BMI), systolic blood pressure (SBP), total cholesterol (TC) and fasting plasma 
glucose (FPG) between 1980 and 2008 [4–7]. BMI levels increased globally regardless of 
economic regions. In contrast, a disparity was observed in the pattern of SBP trends 
between high- and low-income countries. Favourable trends were seen in western 
populations, while the opposite was true in Oceania, in East and West Africa, and in South 
and Southeast Asia. The mean TC level changed little globally, despite marked declines in 
North America, Europe and Australasia. These favourable trends were counterbalanced by 
increases in East and Southeast Asia (also in Japan, China and Thailand) and in Pacific 
subregions. The number of people with diabetes has more than doubled by increasing from 
153 million in 1980 to 347 million in 2008, which was driven by a combination of ageing 
populations due to increasing life expectancy, earlier and more widespread diagnosis of 
previously undetected cases and increases of obesity and physical inactivity. Prevalence 
increased by approximately one percentage point (absolute increase) to 9.8% and 9.2% in 
men and women, respectively. Mean FPG increased the most in North America among 
high-income countries. In 1980, people living in high-income countries had the worst 
cardiometabolic risk factor profiles, but the heterogeneous trends led to a global 
convergence of risk factors [8]. Incidence rates for CVD dropped markedly in high-income 
countries and increased in low- and middle-income countries. The contrasting trends seen 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
a link (accessed on March 23, 2014): 
http://professional.diabetes.org/ResourcesForProfessionals.aspx?typ=17&cid=60397&pcid=60379 
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in high-income regions suggest that the adverse effects of obesity on blood pressure and 
cholesterol could be controlled without reversing the obesity epidemic, although also 
highlight the strong relationship between obesity and diabetes. It also gives the hope and 
calls for action to prevent a possibly huge burden of CVD and diabetes in developing 
countries that are experiencing the effects of globalisation and urbanisation similar to those 
previously seen in western populations. In-depth data collection and novel, sophisticated 
statistical analyses can help to understand the reasons of contrasting trends in risk factors 
and to evaluate the effect of potential prevention strategies. 
The present thesis examines three different epidemiological aspects of 
cardiometabolic risk: the effect of maternal obesity and gestational weight gain (GWG) on 
birthweight; age-related trajectories, secular trends and changing distributions of obesity, 
blood pressure and cholesterol measures; and diurnal variation of glucose measures and its 
consequences on diabetes diagnosis. 
1.1 Maternal obesity and gestational weight gain 
The previously mentioned obesity epidemic affects all age groups and women at 
childbearing age are not exception [9]. Maternal pre-pregnancy BMI and GWG are well-
known determinants of infant birthweight, while both low and high birthweight contribute 
to the risk of adverse pregnancy outcomes and later health problems in offspring. Women 
with adverse BMI values (underweight, overweight and obese) have an increased risk of 
preterm birth and underweight women are more likely to give birth to low birthweight 
infants [10]. On the high end of the BMI distribution, a recent meta-analysis showed that 
the beneficial effect of maternal overweight and obesity on low birthweight seems to 
disappear after adjustment for publication bias [11]. Obese women are also at an increased 
risk of gestational diabetes, preeclampsia, and having a macrosomic infant [12]. GWG is 
known to be a modifiable risk factor that is associated with birthweight, independently 
from maternal BMI. This offers an opportunity to counterbalance the negative effects of 
too low or high pre-pregnancy BMI by optimizing GWG. Current recommendations from 
the Institute of Medicine (IOM) reflect the premise that a larger GWG is acceptable in 
underweight women to prevent small for gestational age (SGA) newborns, while only a 
limited weight gain is desirable in obese women to reduce the risk of large for gestational 
age (LGA) newborns [13, 14]. However, current knowledge and recommendations are 
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based on ordinary least squares (OLS) and logistic regression models that lack detail about 
associations along entire distributions of the continuous outcome variable birthweight. This 
aspect is especially important when analysing determinants of birthweight, when both ends 
of the distribution increase the risk of adverse health outcomes. Therefore, a prevention 
strategy that decreases the variation and kurtosisa of birthweight is preferable compared to 
a strategy that induces a left-shift of the entire birthweight distribution. 
1.2 Secular trends and age-related trajectories of risk factors 
Assessment of age-related risk factor trajectories is an important task for 
epidemiologists from a public health perspective. Knowing the natural progression of risk 
with ageing might help to identify age groups and individuals that should be targeted more 
intensely with prevention strategies. Divergence of an individual’s risk factor trajectory 
from the population mean might be a signal of a worsening cardiometabolic risk profile. 
Although, with mobile devices in the era of information technology, it has never been 
easier to collect repeated measurements from individuals, most of the current CVD risk 
calculators use a single measurement in time. 
Our current knowledge on the age-related progression of cardiometabolic risk 
factors is often still based on analyses comparing mean values in different age groups. 
Such studies cannot capture within-individual changes and might be strongly affected by 
cohort effects. Cohort effects are generated by the interaction of age and period effects 
[15]. These population-wide changes (period effects) find people at different times of their 
life-course, therefore their long-term influence on health might vary between birth cohorts. 
The last few decades brought marked changes in cardiometabolic risk, which makes the 
analysis of age-related trajectories especially challenging. Changes of mean levels give 
only a limited description of secular trends, while changes in risk factor distributions still 
receive little attention. This issue may have important practical implications because the 
Rose prevention paradigm, that has strongly affected public health policy in the past 
decades, assumes that as populations move towards higher CVD risk levels, risk factor 
distributions shift in their entirety to the unfavourable direction [16–18]. Hence, prevention 
of CVD events should target entire populations. However, few studies have examined 
whether changes of risk factor distribution in fact follow this assumption. Most of the 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
a kurtosis measures the “fatness” of a distribution’s tails 
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evidence is on BMI, suggesting that distributions have become increasingly right-skewed 
in the past decades [19, 20], with little right shift of the entire curve. Nevertheless, 
distributions of other risk factors were rarely analysed simultaneously [21]. 
1.3 Diurnal variation of glucose measures 
The consequences of a diabetes diagnosis are lifelong and therefore a diagnosis 
should be made carefully. Current diagnostic criteria are based on threshold values of 
blood glucose measures that “distinguish a group with significantly increased premature 
mortality and increased risk of microvascular and cardiovascular complications” [22].  A 
WHO expert consultation held in 2009 recommended that an HbA1c measure of 6.5% or 
higher should be added to the existing diagnostic criteria (FPG ≥ 7.0 mmol/L or	 2-h post-
load plasma glucose (2hPG) ≥ 11.1 mmol/L ) [23]. Until then, HbA1c was rather used only 
for the assessment of glycaemic control in people with diabetes, because of standardisation 
issues, limited availability and influencing factors (e.g. anaemia) [24].  
Diurnal variation of glucose tolerance was described more than 40 years ago [25–
27]. These studies found higher glucose values after an oral glucose tolerance test (OGTT) 
when measured in the afternoon rather than in the morning. The limitation of the results 
were the small sample size or/and that time was recorded as a categorical variable 
(morning versus afternoon). More recent studies focused on fasting glucose [28–30]. To 
our best knowledge, none of the studies analysed the combined effect of time of day and 
fasting duration on all three glucose measures. 
Recommendations regarding the time of an OGTT and fasting duration according 
to a WHO Report include the following: “The OGTT should be administered in the 
morning after at least three days of unrestricted diet (greater than 150 g of carbohydrate 
daily) and usual physical activity. … The test should be preceded by an overnight fast of 8-
14 hours, during which water may be drunk.” [31]. The given conditions regarding timing 
are very permissive and previous evidence suggests that even if following them, measures 
can vary by time of day and fasting duration. Therefore we hypothetized that there may be 
remaining heterogeneity in the results of OGTTs even if they are performed according to 
the current instructions, and that the magnitude of this heterogeneity has the potential to 
affect the number of diabetes diagnoses in large epidemiological studies. 
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2 AIMS 
The general purpose of the studies included in the thesis was to reveal complex 
associations and features related to cardiometabolic risk factors and their distributions on a 
population level that cannot be described adequately with conventional statistical methods. 
Therefore, we applied sophisticated methodologies to analyse data from relatively large 
epidemiological studies. The studies included in this thesis investigate cardiometabolic risk 
from three different epidemiological perspectives. The specific aims of the studies were the 
following: 
• To characterise the effect of pre-pregnancy BMI and maximal GWG on the entire 
distribution of birthweight, and not only on its mean value. We also wanted to 
compare how a hypothetical population-based and a high-risk intervention 
strategy promoting a more modest GWG would perform in the prevention of low 
birthweight and macrosomia. 
• To investigate how secular trends affected cardiometabolic risk factor 
distributions (e.g. location shift or changing skewness) in the last three decades by 
applying non-parametric statistical methods. We also aimed to examine age-
related risk factor trajectories and how these were affected by secular trends. 
• To explore the individual and the joint effect of time of day and fasting duration 
on FPG, 2hPG and HbA1c and to assess whether these associations are affected by 
ageing and obesity. We also aimed to evaluate the effect of timing on the 
incidence of diabetes in a large occupational cohort study. 
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3 METHODS – GENERAL OVERVIEW 
This section gives a brief introduction to quantile regression and to mixed-effects 
models. These two methods are not commonly used in epidemiology and have a key role 
in this thesis. 
3.1 Quantile regression 
Ordinary least squares (OLS) regression is probably one of the most often used 
biostatistical method in epidemiology. The interpretation of its results is straightforward: 
regression coefficients represent the difference in the mean value of the outcome per unit 
difference in explanatory variables. This simplicity comes with a price, that was first 
phrased by Mosteller and Tukey in the 1970’s [32]: 
“What the regression curve does is give a grand summary for the averages of 
the distributions corresponding to the set of x’s. We could go further and compute 
several different regression curves corresponding to the various percentage points 
of the distributions and thus get a more complete picture of the set. Ordinarily this 
is not done, and so regression often gives a rather incomplete picture. Just as the 
mean gives an incomplete picture of a single distribution, so the regression curve 
gives a corresponding incomplete picture for a set of distributions.”  
Mosteller, Tukey (1977) 
By using OLS linear regression, we can only make statements about how changes 
in explanatory factors shift the mean of the outcome’s distribution [33]. In case of a 
dichotomised outcome variable (based on a threshold value of a continuous variable), 
logistic regression reveals changes in a particular part of the distribution without regard to 
the rest of the distribution. In contrast, quantile regression can shed light on associations at 
any given point of the outcome’s distribution (defined by its quantile), not only on the 
mean or specific parts based on threshold values. Coefficients from a quantile regression 
e.g. for the 50th percentile are interpreted similarly to OLS regression, with the exception 
that they do not represent differences in the mean, but in the 50th percentile. By fitting the 
same regression model for various quantiles/percentiles, we can get a picture of the 
explanatory variable’s effect on the entire distribution of an outcome. If a population-wide 
change in an explanatory variable shifts the entire outcome distribution, we expect to see 
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very similar (constant) regression coefficients along the percentiles of the outcome. In 
contrast, if the shape (skewness, kurtosis) of the outcome distribution is also affected, 
coefficients will vary systematically by percentiles. This heterogeneity of effect sizes 
cannot be described with regression models focusing on the mean. 
Quantile regression was developed and then used in econometrics since the late 
1970s [34, 35]. The literature of its applications in epidemiology are very limited, although 
there seems to be an increase in the last few years. The lack of appropriate software not 
limit its application, as packages for fitting quantile regression are available in the most 
commonly used statistical software. In the quantile analyses of this thesis, the quantreg 
package (version 4.97) was used in the R language (R Foundation for Statistical 
Computing, Vienna, Austria) [36]. The exact mathematical description of model fitting is 
beyond the scope of the thesis and is described elsewhere [34]. 
3.2 Mixed-effects models 
Until the early 1980’s when the first adequate models were developed, there had 
been a debate on whether change should be measured longitudinally and could be analysed 
appropriately [37]. The use of OLS regression and cross-sectional data are not sufficient, 
because it is impossible to separate true change from cohort and period effects. A mixed-
effects model can be regarded as an extension of a classical regression model that contains 
both fixed and random effects. Some variants of mixed-effects models are also known as 
multilevel models when analysing data with a hierarchical or nested structure. Probably the 
most common application of such models in epidemiological studies is the analysis of 
change over time based on repeated measures data. In this case, measurements are nested 
within individuals, which induces a special correlation structure in the data that cannot be 
dealt with using classical regression methods. The formulation of an unconditional growth 
model is shown in Table 1 using labeling conventions from Willett & Singer [37]. Random 
effects (ζ 0i ,ζ1i ) are introduced to the models to allow varying parameters (e.g. intercept, 
slope) between individuals. 
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Table 1 General formulation of a mixed-effects (multilevel) model. 
Level-1 equation 
yij = π 0i +π1i ⋅ timeij + ε ij   
Level-2 equations 
π 0i = γ 00 +ζ 0i
π1i = γ 10 +ζ1i
  
yij : outcome at time j of individual i 
π 0i ,π1i : intercept and slope for individual i 
timeij : time of jth measurement of individual i 
ε ij : random measurement error at time j of individual i 
γ 00,γ 10 : population average of intercept and slope (fixed effects) 
ζ 0i ,ζ1i : deviations of individual parameters (intercept and slope) from population 
averages (random effects) 
The level-1 equation specifies the pattern of within-individual change (linear 
trajectory in this example), whereas the level-2 equations are responsible for the inter-
individual differences in change. Willet & Singer phrase the main questions for 
longitudinal analyses of change that correspond to the two levels: (1) “How does the 
outcome change over time?” and (2) “Can we predict differences in these changes?”. 
Mixed-effects models do not only extend classical regression methods, but also 
offer some advantages over classical statistical methods for repeated measures (e.g. 
repeated measures analysis of variance). Both time-varying and time-invariant predictors 
can be included in the models, which is a common approach in epidemiology to adjust for 
confounders. Mixed-effects models do not require that measurements are equally spaced in 
time. They are also flexible by allowing a varying number of measurements per 
individuals. Because model fitting is likelihood-based, mixed-effects models give valid 
estimates if data is missing completely at random (MCAR) or missing at random (MAR) 
[38]. If data is missing not at random (MNAR), sensitivity analyses should be conducted. 
Unfortunately, there is no hypothesis test to decide which missingness pattern is present. 
Data for cross-sectional analyses are usually stored in a “person-level” format, 
where one record (row) belongs to each individual. When analysing longitudinal data  with 
	   14 
mixed-effects model,  a “person-period” data format is used, where each measurement 
occasion is organised into a separate record. Most of the commonly used statistical 
software provides functionality to do this data transformation. In the analyses of this thesis, 
models were fitted with the lme4 package (version 0.99) in the R statistical computing 
environment [39]. Figures of trajectories and distributions were created in Wolfram 
Mathematica 9 (Wolfram Research, Champaign, IL, USA). 
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4 METHODS - SPECIFIC STUDY SETTINGS AND ANALYSES 
4.1 Maternal obesity and gestational weight gain 
4.1.1 Gestational diabetes screening at the Szent Imre Hospital, Budapest 
In this study, we analysed data from a population-based gestational diabetes 
mellitus (GDM) screening conducted at the Szent Imre Teaching Hospital between 2002 
and 2005 in Budapest, Hungary. The screening program was supported by the Hungarian 
Medical Research Council (ETT 254/2000) and approved by the Szent Imre Hospital’s 
Ethics Committee. The hospital serves a rather affluent, urbanised population of 200,000. 
Altogether, 5,335 pregnancies were registered during the study period. After excluding 
twin pregnancies (n=122), stillbirths (n=19) and records with missing birthweight values  
(n=19) or other covariates (n=250), the final dataset included 4,925 cases (92% of all 
pregnancies). Data on covariates and outcomes were collected with questionnaires at the 
time of the OGTT between week 22 and 30 of gestation, immediately after delivery or 
were extracted from hospital records. Maternal age, ethnicity, education, smoking status, 
parity, pre-pregnancy weight, maximal GWG and treatment for GDM were recorded. 
Gestational age was based on the date of the last menstrual period and an ultrasound 
examination during the first trimester. Height was measured by a trained nurse. BMI was 
calculated as the ratio of pre-pregnancy weight (in kg) and the square of height (in m2). 
Infants’ birthweight and sex were extracted from hospital documentation. Low birthweight 
and macrosomia were defined using the 2500 g and 4000 g cut-offs, respectively. A more 
detailed description of the study procedures is available elsewhere [40]. 
4.1.2 Distributional associations of maternal obesity and birthweight 
We analysed the BMI-birthweight and the GWG-birthweight associations with 
multivariable quantile regression. Models were fitted for the 5th, 15th, … and 95th 
percentiles of the outcome (birthweight) distribution. Models were mutually adjusted for 
BMI and GWG. We further investigated the modifying effect of BMI on the GWG-
birthweight association by including the BMI×GWG interaction in the models. All 
analyses were adjusted for week of delivery, infant’s sex, maternal education, ethnicity, 
age, height, smoking status, parity and interventions (diet or insulin treatment) during 
pregnancy. Classical regression models were also fitted with exactly the same variables, so 
that we could compare the results of the two different methods. 
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4.1.3 Evaluation of hypothetical prevention strategies 
We estimated the effect of a hypothetical population-based (-2 kg GWG among all 
women) and a high-risk (-3 kg GWG among overweight and obese women) prevention 
strategy by utilising coefficient estimates from the quantile regression models. The 
birthweight distribution was divided into 10 intervals by the deciles. Each of the previously 
defined 10 quantile regression models corresponded to one of these intervals (e.g. 
regression for the 35th percentile of birthweight belongs to the interval between the 30th 
and 40th percentile). Therefore we could account for the heterogeneity of associations by 
estimating birthweights after the hypothetical prevention strategies using coefficient 
estimates from the specific corresponding quantile regression models (Table 2). The 
proportion of low birthweight and macrosomic infants, and the standard deviation (SD) of 
birthweight (a measure of dispersion of the outcome) were calculated from the new 
hypothetical birthweight distribution. These efficacy measures were based on non-
parametric smooth kernel distributions to avoid inconsistency of definitions in the 
literature (e.g. >4000 g and ≥4000 g for macrosomia etc.) and inaccuracy introduced by 
rounding birthweights.  
Table 2 Calculation of birthweights after a hypothetical prevention strategy. 
BWafter = BWactual − D ⋅(CoefGWG ,i +CoefGWG×BMI ,i ⋅BMI )  
BWafter : birthweight following a given hypothetical intervention 
BWactual : original birthweight 
D : GWG decrease according to the strategy (population-based: 2 kg; high-risk: 3 
kg if overweight or obese, 0 kg otherwise) 
CoefGWG ,i ,CoefGWG×BMI ,i : coefficients of GWG and GWG×BMI from the quantile 
regression at the location of birthweight in the distribution (in the ith interval) 
BMI : maternal pre-pregnancy body mass index 
4.2 Secular trends and age-related trajectories of risk factors 
4.2.1 The Whitehall II study 
The Whitehall II study is an occupational cohort of British civil servants, set up 30 
years ago to investigate social and occupational differences in health and disease [41]. 
Cardiovascular disease and diabetes played an important role in the scientific contributions 
of the study [42–44]. 
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Between 1985 and 1988, 10,308 men and women (73% of those invited), aged 35-
55 years and employed in London-based government departments, participated in the first 
phase of the Whitehall II study. Participants differed widely in employment level from 
clerical to senior administrative grades. Two thirds of them were men. Clinical 
examinations in addition to postal questionnaires were part of every second phase, i.e. 
phase 1 in 1985-88, phase 3 in 1991-94, phase 5 in 1997-99, phase 7 in 2002-04 and phase 
9 in 2007-09, when the entire cohort was invited to the research clinic. This resulted in up 
to five repeated measurements per individuals. The University College London ethics 
committee reviewed and approved the study. Written informed consent was obtained from 
all participants at each study phase. The exact number of participants at each phase is 
displayed in Table 3. The attrition rate was the highest between phase 1 and 3 with 13%. 
Loss to follow-up because of non-response or death until phase 9 was 31% and 41% 
among men and women, respectively. 
Table 3 Summary of participation status at each study phase. Number of participants and 
cumulative number of deaths and non-responses are reported. 
 Phase 1 1985-1988 
Phase 3 
1991-1994 
Phase 5 
1997-1999 
Phase 7 
2002-2004 
Phase 9 
2007-2009 
Men      
Participated 6895 6057 5473 4893 4759 
Died  81 204 389 621 
Non-response  757 1218 1613 1515a 
Women      
Participated 3413 2758 2397 2074 2002 
Died  44 102 195 333 
Non-response  611 914 1144 1078a 
aCumulative numbers may decrease, because we had information about the death of participants, even if they 
did not respond in a previous phase. 
Anthropometric measures were assessed by trained research nurses according to 
standardised protocols. Waist circumference (WC) was first measured in phase 3, when the 
smallest value was recorded below the costal margin. SBP and diastolic blood pressure 
(DBP) were measured twice in a seated posture after a minimum of 5 minutes rest, and the 
average values were used in the analyses. A manual random zero sphygmomanometer 
(MRZ) was used in phases 3 and 5, and an automated oscillometric device (AOD) in 
phases 7 and 9. Further details on blood pressure measures can be found in [45]. The 
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biochemical analysis of blood samples to assess TC and high-density lipoprotein (HDL) 
cholesterol values is described in details elsewhere [46]. 
4.2.2 Sequential cross-sectional analysis 
Secular trends were first investigated in a subgroup of participants aged 57-61 (to 
exclude the effect of ageing) with sequential cross-sectional analyses stratified by sex. This 
age group was not represented at phase 1, when participants were at 35-55 years of age, so 
the study period for this analysis was 18-year long (1991-2009). We first described 
changes in BMI, WC, SBP, DBP, TC and HDL by calculating the 10th, 50th and 90th 
percentiles at each phase. Linear trends were estimated for these specific percentiles with 
quantile regression models using calendar year as the explanatory variable. We kept 
calendar year as a continuous rather than a categorical variable, as study phases were 
normally 2-3 years long providing more values in the valid range. Non-parametric smooth 
kernel distributions (using Gaussian kernels) were fitted to the data to get an overall 
picture of distributional changes (location and shape) between phases. 
4.2.3 Longitudinal analysis 
Quadratic age-related risk factor trajectories for the mean were assessed by fitting 
mixed-effects models with random intercepts for the entire Whitehall II cohort, stratified 
by sex. Year of birth and its interaction terms with age and age-squared were included in 
the models to investigate secular trends and cohort effects (Table 4). Using these model 
terms, we could account for possible differences in trajectory characteristics (level and 
curvature) between birth cohorts. We conducted sensitivity analyses to investigate the 
possible impact of data being MNAR. The models described above were fitted to a 
relatively healthier subgroup of participants who participated up to phase 9 (not necessarily 
in each phase until then) to test the robustness of our results against selective loss of 
follow-up and healthy survival. 
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Table 4 Model form of age-related trajectories. 
RF = CoefIntercept + (CoefAge +CoefYB×Age ⋅YB) ⋅Age+ (CoefAge2 +CoefYB×Age2 ⋅YB) ⋅Age2  
RF : risk factor (BMI, WC, SBP, DBP, TC, HDL) 
Coef... : estimated model coefficients 
YB : year of birth 
Age : age 
4.3 Diurnal variation of glucose measures 
4.3.1 Glucose measures in the Whitehall II study 
We analysed data from the Whitehall II study, which was previously described. 
FPG and 2hPG measures were assessed with a 75-g OGTT with glucose measurements at 
0 and 120 minutes (starting times between 08:00 and 15:00 hours) that was part of the 
clinical examination from phase 3 onward. HbA1c was measured in phases 7 and 9. Blood 
samples were handled according to standard protocols: samples were drawn into fluoride 
monovette tubes (to prevent glycolysis), which were centrifuged on site within 1 hour. 
Plasma was transferred into microtubes immediately after centrifugation and stored 
at -70 oC. The biochemical analysis to assess FPG, 2hPG and HbA1c values is described in 
details elsewhere [42]. Time of fasting blood draw was recorded by a trained nurse as 
HH:MM on the participant’s clinical report form based on a standardised clock in the 
examination room. Fasting duration was calculated from the time of the last meal, which 
was self-reported. Participants of white ethnicity and with valid glucose measures were 
considered in this analysis. Person-examinations were excluded because of the following 
reasons: participant was previously diagnosed with diabetes or was currently on glucose-
lowering treatment (n=1,266), unrealistic fasting duration (last meal before 17:00 hours on 
the previous day or after 01:00 hours on the day of the OGTT, n=334) or missing 
contemporary anthropometric measures (n=407). The final dataset included 5,978 
participants (with 13,269 person-examinations) of white ethnicity, from 40 to 80 years of 
age. 
4.3.2 Association between fasting status, time of OGTT and glucose measures  
The effect of time of day and fasting duration on glucose measures (FPG, 2hPG 
and HbA1c) was assessed with age- and BMI-adjusted mixed-effects models that were 
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stratified by sex. Models with 2hPG as outcome variable included further adjustment for 
height, as previously suggested [47]. All models were adjusted for study phase (included as 
a categorical variable) to model potential phase-specific, systematic differences in 
measurements. To handle the within-person correlation arising from the longitudinal 
structure of the data, random effects for the intercept were included in the models. We also 
fitted all models with standardised outcomes to investigate the relative effect of timing 
factors on glucose measures. After the individual effect of time of day and fasting duration 
had been examined, all models were fitted with both variables at the same time. Deviance-
based hypothesis tests were used to investigate whether this improved model fit. The effect 
of ageing and BMI on diurnal variation was analysed by including the appropriate 
interaction terms in the models. 
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5 RESULTS 
5.1 Maternal obesity and gestational weight gain 
General characteristics of the study population are displayed in Table 5. 
Participants were relatively lean with a mean BMI of 22.7 ± 4.1 kg/m2 and low prevalence 
of overweight (15%) and obesity (6%). They were predominantly Caucasian (98%) and 
abstained from smoking during pregnancy (95%). Almost 90% of participants finished at 
least high school. 
Table 5 Characteristics of study population from the GDM in Budapest (2002-2005). 
 % Mean ± SD (Q1-Q3) 
Maternal   
Age (years)  29.3 ± 4.3 (27-32) 
Caucasian (%) 98.1  
Education (%)   
Less than high school 12.7  
High school 39.2  
College 48.1  
Parity (%)   
0 55.1  
1-2 41.0  
≥3 3.9  
Intervention (%)   
None 93.5  
Diet 5.1  
Insulin treatment 1.4  
Any smoking during pregnancy (%) 5.2  
Height (cm)  166.5 ± 6.4 (163-170) 
Pre-pregnancy BMI (kg/m2)  22.7 ± 4.1 (20.0-24.3) 
Gestational weight gain (kg)   12.8 ± 5.0 (10-16) 
Newborn   
Gestational age at delivery (weeks)  39.1 ± 1.9 (39-40) 
Birthweight (g)  3,446 ± 465 (3,150-3,750) 
Male sex (%) 51.5  
Maternal GWG and pre-pregnancy BMI were both positively associated with 
birthweight (in a mutually adjusted model). Effect sizes increased towards higher 
percentiles of the birthweight distribution, especially for pre-pregnancy BMI (Figure 2). 
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Classical regression models described the association well only in the middle region of the 
birthweight distribution. 
  
Figure 2 Effect of pre-pregnancy BMI (A) and gestational weight gain (B) on birthweight 
with 95% CIs along the birthweight distribution (by quantile) from quantile regression 
(solid lines) and classical linear regression (dashed lines) models 
The effect of GWG on birthweight was modified by pre-pregnancy BMI, which 
was analysed by adding the GWG×BMI interaction to the previous models. Coefficient 
estimates for GWG at a BMI of 20 and 30 kg/m2 are displayed in Figure 3. Estimates from 
classical linear regression models are displayed with dashed lines. At a pre-pregnancy BMI 
of 20 kg/m2, a 1 kg difference in GWG was associated with a 10.2 [95% CI: 6.1; 14.5] g 
and 23.1 [17.5; 29.0] g higher birthweight at the 5th and 95th percentile of birthweight, 
respectively. In contrast, at a pre-pregnancy BMI of 30 kg/m2, we did not observe an 
increasing trend by quantile in effect sizes, which ranged from 18.6 to 26.0 g along the 
birthweight distribution. 
  
Figure 3 Effect of gestational weight gain on birthweight with 95% CIs along the 
birthweight distribution (by quantile) for two different BMI values: 20 kg/m2 (A) and 30 
kg/m2 (B), from quantile regression (solid lines) and classical linear regression (dashed 
lines) models 
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The effects of our hypothetical prevention strategies on birthweight related 
pregnancy outcomes are summarised in Table 6. Calculations based on quantile regression 
models showed that the relative decrease in the proportion of macrosomic infants (-15%) 
was greater than the increase in low birthweight (+12%) after a hypothetical population-
based prevention strategy. Using coefficient estimates from classical regression models 
resulted the opposite (-13% and +17%, respectively). The high-risk strategy slightly 
increased the proportion of low birthweight infants, but the presence of macrosomia 
decreased only by 6%. 
Table 6 Efficacy of hypothetical prevention strategies (based on quantile regression 
coefficients) promoting a more modest gestational weight gain. 
Prevention strategy Macrosomia % 
Low birthweight 
% 
SD 
g 
Observed data 11.2 2.3 470 
Population-based (-2 kg GWG) 9.6 2.5 465 
High-risk (-3 kg GWG if BMI ≥	 25 kg/m2) 10.5 2.3 467 
Values are based on non-parametric smooth kernel distributions. 
5.2 Secular trends and age-related trajectories of risk factors 
Baseline characteristics of the Whitehall II cohort are shown in Table 7. Women 
had generally lower employment grades and were more likely to be current smokers than 
men. WC and HDL cholesterol differed the most between sexes. 
5.2.1 Distributional trends (age group: 57-61 years) 
Risk factor percentiles (10th, 50th, 90th) for phases 3, 5, 7 and 9 and linear trends 
from quantile regression models are displayed in Table 8. Smooth kernel distributions are 
shown in Figure 4. 
Changes in the BMI distribution of men were characterised by a right-shift of the 
median and a fattening right tail. Increments were heterogeneous along the distribution and 
were the largest at the 90th percentile (+2.8 kg/m2). For women the low BMI segment 
remained unchanged, but the 90th percentile increased by 2 kg/m2 leading to a fat tail on 
the right. 
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Table 7 Baseline characteristics of the Whitehall II cohort (1985-1988). Values are 
medians (Q1-Q3) or percentages. 
 Men (n=6,895) Women (n=3,413) 
Age (year) 43 (39-49) 45 (40-51) 
Whites (%) 91.5 84.2 
Smoking (%)   
Never 47.3 52.9 
Ex 36.1 23.3 
Current 15.8 23.3 
Missing 0.8 0.5 
Grade level (%)   
Administrative 38.4 11.2 
Prof/Executive 52.3 39.1 
Clerical/Support 9.3 49.7 
BMI (kg/m2) 24.3 (22.6-26.2) 24.0 (21.9-26.7) 
WCa (cm) 88.9 (83.0-94.7) 76.5 (69.5-85.4) 
SBP (mmHg) 123 (115-133) 118 (109-130) 
DBP (mmHg) 77 (71-84) 75 (68-81) 
TC (mmol/l) 5.9 (5.2-6.7) 5.8 (5.1-6.6) 
HDL-C (mmol/l) 1.3 (1.1-1.6) 1.6 (1.4-2.0) 
aWC measures are from phase 3 (1991-1994). 
In contrast with BMI, WC increased along the entire distribution. The increment 
was largest at the right end of the distribution (+8 cm at the 90th percentile) in both men 
and women. The change in SBP was not consistent: it increased until phase 7 and then 
dropped markedly at phase 9. Therefore the linear trend cannot be interpreted. In contrast 
the entire DBP distribution shifted to the left by approximately 10 mmHg in both men and 
women. 
The linear trend was of similar magnitude along the entire TC distribution, which 
led to a left-shift of the distribution with 1.5 mmol/l in both men and women. Changes in 
HDL cholesterol were modest compared to TC, although all percentiles increased by 0.1-
0.2 mmol/l. 
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Table 8 Secular trends based on percentiles of risk factors in men and women.  
Men Percentile Phase 3 n=911 
Phase 5 
n=903 
Phase 7 
n=1,222 
Phase 9 
n=1,391 
Linear trenda (per year) 
β [95% CI]  
BMI 
(kg/m2) 
10th 21.9 22.2 22.4 21.9 0.004 [-0.014; 0.027] 
50th 25.1 25.6 26.1 26.4 0.080 [0.065; 0.096]*** 
90th 29.1 30.4 31.8 31.9 0.192 [0.145; 0.234]*** 
WC 
(cm) 
10th 78.4 80.3 81.2 80.6 0.152 [0.100; 0.210]*** 
50th 88.2 91.9 93.6 94.2 0.360 [0.318; 0.409]*** 
90th 101.4 105.2 108.4 109.6 0.508 [0.433; 0.631]*** 
SBP 
(mmHg) 
10th 107 106 109 107 0.000 [-0.086; 0.092] 
50th 125 123 126 124 0.000 [-0.031; 0.083] 
90th 145 148 150 143 -0.181 [-0.313; -0.030]* 
DBP 
(mmHg) 
10th 71 65 61 60 -0.654 [-0.714; -0.603]*** 
50th 82 78 75 73 -0.594 [-0.653; -0.517]*** 
90th 95 91 89 85 -0.577 [-0.650, -0.490]*** 
TC 
(mmol/l) 
10th 5.3 4.8 4.5 4.0 -0.079 [-0.085; -0.074]*** 
50th 6.7 5.9 5.7 5.2 -0.083 [-0.088; -0.077]*** 
90th 8.1 7.3 7.0 6.6 -0.086 [-0.093; -0.079]*** 
HDL-C 
(mmol/l) 
10th 0.9 1.0 1.0 1.0 0.005 [0.003; 0.008]*** 
50th 1.3 1.3 1.4 1.4 0.008 [0.004; 0.010]*** 
90th 1.8 1.9 1.9 2.0 0.011 [0.009; 0.013]*** 
 
Women Percentile Phase 3 n=520 
Phase 5 
n=383 
Phase 7 
n=492 
Phase 9 
n=514 
Linear trenda (per year) 
β [95% CI]  
BMI 
(kg/m2) 
10th 21.3 21.2 21.2 21.1 -0.007 [-0.043; 0.021] 
50th 26.0 25.8 25.8 26.1 0.000 [-0.023; 0.025] 
90th 32.8 32.5 33.8 34.8 0.120 [0.063; 0.205]** 
WC 
(cm) 
10th 64.9 68.0 68.1 69.9 0.289 [0.190; 0.351]*** 
50th 78.4 80.0 81.0 83.0 0.276 [0.173; 0.391]*** 
90th 96.0 96.3 100.2 104.0 0.482 [0.354; 0.657]*** 
SBP 
(mmHg) 
10th 104 103 104 99 -0.277 [-0.406; -0.091]** 
50th 122 123 123 116 -0.350 [-0.516; -0.202]*** 
90th 141 148 147 141 0.094 [-0.141; 0.278] 
DBP 
(mmHg) 
10th 66 64 60 56 -0.634 [-0.707; -0.524]*** 
50th 78 75 72 69 -0.558 [-0.647; -0.491]*** 
90th 90 89 88 84 -0.359 [-0.464; -0.201]*** 
TC 
(mmol/l) 
10th 5.8 4.9 4.7 4.4 -0.084 [-0.093; -0.071]*** 
50th 7.0 6.1 5.9 5.5 -0.084 [-0.093; -0.078]*** 
90th 8.8 7.6 7.3 6.9 -0.115 [-0.122; -0.098]*** 
HDL-C 
(mmol/l) 
10th 1.2 1.2 1.3 1.3 0.009 [0.007; 0.010]*** 
50th 1.6 1.6 1.8 1.8 0.012 [0.010; 0.019]*** 
90th 2.3 2.2 2.5 2.5 0.015 [0.011; 0.023]*** 
*p<0.05, **p<0.01, ***p<0.001 
aLinear trends were assessed with quantile regression models. 
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Men   
   
   
   
Women   
   
   
Figure 4 Smooth kernel distributions of risk factors (probability density functions are 
displayed) in men and women (dotted line: phase 3, dashed line: phase 5, solid line: phase 
7, thick line: phase 9) 
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Changes in the proportion of smokers and people on either lipid-lowering or 
antihypertensive treatment are shown in Table 9. Fewer women smoked in the later phases, 
while the number of smokers among men remained constant around 8%. Both lipid-
lowering and antihypertensive medication usage increased drastically. Between 2007 and 
2009 approximately every fourth person was on treatment in the 57-61 age group. 
Table 9 Secular trends of smoking habits, lipid-lowering and antihypertensive medication. 
 Phase 3 Phase 5 Phase 7 Phase 9 
Men     
Current smoker 8.5 8.8 8.7 7.9 
Lipid treatment 1.4 4.1 10.6 24.0 
Anti-hyp. treatment 12.4 15.2 21.9 28.0 
Women     
Current smoker 15.9 10.6 11.3 4.7 
Lipid treatment 2.0 4.1 7.9 19.9 
Anti-hyp. treatment 16.9 20.9 20.9 24.8 
Values are percentages. 
5.2.2 Age-related trajectories 
Age-related trajectories (unadjusted and adjusted for four different year of births) 
of cardiometabolic risk factors - based on data from the entire Whitehall II cohort – are 
displayed in Figure 5. 
BMI and WC increased faster with age and were at higher levels at any given age 
in younger birth cohorts than in older. The BMI difference between those born in 1933 and 
1948 at age 60 was 1.3 [1.1; 1.5] kg/m2 and 0.5 [0.1; 0.9] kg/m2 in men and women, 
respectively. The increasing trend of BMI was more marked in men, while women had 
steeper BMI and WC trajectories in mid-life. 
SBP increased faster between ages 40 and 75 in women than in men: 15.1 mmHg 
versus 8.9 mmHg, which was a 12.9% and 7.2% relative increase, respectively. Younger 
generations had generally lower mean SBP, except elderly men. The unadjusted mean 
DBP trajectory had its peak around age 50 and then declined markedly. In the adjusted 
models, younger generations’ trajectories started to decline earlier and had lower DBP at 
any age. 	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Men   
   
   
   
Women   
   
   
Figure 5 Age-related trajectories of risk factors in men and women with adjustment for 
four different birth cohorts: 1933 (), 1938 (), 1943 (), 1948 () and unadjusted (---) 
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The unadjusted TC trajectory of men increased up to age 47, peaking at 6.2 [6.2; 
6.3] mmol/l. In women, the peak occurred slightly later at age 52, when the peak value was 
6.3 [6.3; 6.4] mmol/l. At age 60, men born in 1948 had 1.1 [1.0; 1.2] mmol/l lower TC 
level than men born in 1933, whereas for women the difference between these birth 
cohorts was 1.2 [1.1; 1.3] mmol/l. Women had a higher mean HDL cholesterol level than 
men from mid- to late-adulthood. We observed a modest increase with both age and 
calendar year. 
We found similar associations in our sensitivity analyses when fitting trajectories to 
a subsample of participants who attended up to phase 9 (data not shown). 
5.3 Diurnal variation of glucose measures 
OGTTs were performed between 08:00 and 15:00 (median 10:42, Q1-Q3: 
9:50-11:36), whereas fasting duration ranged from 8 to 20 hours (median 13.4, Q1-Q3: 
12.1-14.9). Time of day and fasting duration were moderately correlated (Pearson r = 0.6, 
p<0.001). 
The effect of time of day and fasting duration are summarised in Table 10. FPG 
was inversely associated with both time of day and fasting duration. The mean difference 
in FPG between measures at 08:00 and 15:00 was -0.46 [-0.50; -0.42] mmol/l in men 
and -0.39 [-0.46; -0.31] mmol/l in women. The effect of fasting duration was markedly 
attenuated after including both predictors in the model. Time of day and fasting duration 
were positively associated with 2hPG. The mean difference between measures at 08:00 and 
15:00 was 1.39 [1.25; 1.52] mmol/l in men and 1.19 [0.96; 1.42] mmol/l in women. Time 
of day and fasting duration were independently associated with 2hPG even after the 
inclusion of both variables in the model. HbA1c levels were neither associated with time of 
day nor with fasting duration. Models with standardised outcome variables showed that the 
relative impact of time of day and fasting duration on FPG and 2hPG were similar of 
magnitude, but in the opposite direction (Figure 6). 
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Table 10 Estimated coefficients of time of day (TD) and fasting duration (FD) from age- 
and BMI-adjusted mixed-effects models for FPG, 2hPG and HbA1c with 95% CI. 
Model variables Men Women 
FPG (mmol/l)   
Only TD (h) -0.066 [-0.072; -0.059]*** -0.055 [-0.066; -0.044]*** 
Only FD (h) -0.033 [-0.037; -0.028]*** -0.024 [-0.031; -0.017]*** 
TD and FD   
TD (h) -0.059 [-0.067; -0.050]*** -0.053 [-0.067; -0.039]*** 
FD (h) -0.007 [-0.012; -0.001]* -0.002 [-0.011; 0.007] 
2hPG (mmol/l)   
Only TD (h) 0.198 [0.179; 0.217]*** 0.170 [0.137; 0.203]*** 
Only FD (h) 0.124 [0.111; 0.137]*** 0.103 [0.083; 0.124]*** 
TD and FD   
TD (h) 0.128 [0.102; 0.154]*** 0.111 [0.068; 0.154]*** 
FD (h) 0.068 [0.051; 0.085]*** 0.058 [0.030; 0.085]*** 
HbA1c (%)   
Only TD (h) 0.000 [-0.007; 0.007] -0.006 [-0.018; 0.006] 
Only FD (h) 0.000 [-0.004; 0.005] -0.003 [-0.011; 0.005] 
TD and FD   
TD (h) -0.001 [-0.009; 0.008] -0.005 [-0.021; 0.011] 
FD (h) 0.001 [-0.005; 0.006] -0.001 [-0.012; 0.009] 
 
 
	  
Figure 6 Standardised coefficient estimates of time of day (TD) and fasting duration (FD) 
for men (squares) and women (circles) with 95% confidence intervals. Displayed values 
are the differences caused by an our difference in TD and FD given in standard deviation  
of each outcome variable 
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The modifying effect of age and BMI on the diurnal variation (effect of time of 
day) of glucose measure is summarised in Table 11. A higher BMI, but not increased age 
was associated with larger diurnal variation in FPG. We observed the opposite relationship 
for 2hPG: diurnal variation increased with ageing, but not with BMI. 
Table 11 Diurnal variation of fasting plasma glucose by BMI and glucose tolerance 
(2hPG) by age (in mmol/l per 1 hour). 
FPG 
BMI (kg/m2) 
22 26 30 
men -0.05 [-0.05; -0.04] -0.07 [-0.07; -0.06] -0.09 [-0.10; -0.08] 
women -0.04 [-0.05; -0.02] -0.05 [-0.07; -0.04] -0.07 [-0.09; -0.06] 
 
2hPG 
Age (years) 
45 60 75 
men 0.15 [0.12; 0.18] 0.22 [0.19; 0.24] 0.28 [0.23; 0.33] 
women 0.12 [0.06; 0.17] 0.19 [0.16; 0.23] 0.27 [0.19; 0.35] 
We modelled the hypothetical situation that all OGTTs started at 09:00 to 
investigate the effect of our findings on the diagnosis of diabetes in a clinical setting. The 
difference between the actual time of the OGTT and 09:00 was calculated (as a real 
number in hours) and multiplied with the effect size of time of day from the mixed-effects 
model. This value was added to the actual glucose measures. In this scenario, we found 
that 15% of people with WHO-defined diabetes would have not received a diabetes 
diagnosis. This was mainly driven by lower 2hPG values when measured hypothetically in 
the morning. The number of people with “newly” diagnosed diabetes was not clinically 
relevant. 
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6 DISCUSSION 
6.1 Maternal obesity and gestational weight gain 
In this study, we investigated the association between BMI, GWG and birthweight 
with quantile regression, a method that allows us to explore associations along the entire 
distribution of an outcome. We discuss our results from a public health perspective. 
6.1.1 Geoffrey Rose’s population approach 
Geoffrey Rose’s population strategy still shapes public health practice and 
preventive medicine [16–18]. His original idea poses that a smaller shift of the entire 
distribution of exposure is likely to have a larger impact on risk reduction on a population 
level, than a targeted approach focusing exclusively on high-risk individuals. This topic 
still sparks debate in the literature of epidemiology [48–50]. Sophisticated statistical 
models are necessary to evaluate the effect of hypothetical prevention strategies. Classical 
regression models focusing on mean values cannot model distributional changes in an 
outcome variable, because that would assume homogeneity in associations along the entire 
outcome distribution. Our results showing varying effect sizes of BMI and GWG makes it 
clear that the assumption of homogeneity does not hold for the BMI-birthweight and the 
GWG-birthweight association. Use of classical regression may result in an underestimation 
of the expected decrease in macrosomia and an overestimation of the increase in low 
birthweight for a given population-wide reduction in GWG. Such results may lead to false 
conclusions and even decisions on prevention policies. Our analyses suggest that quantile 
regression is a more suitable tool to describe complex associations than classical regression 
and calls for further methodological studies to describe and promote statistical models 
beyond mean regression [51]. Using coefficients estimates from the quantile regression 
models, we quantified the effect of two hypothetical prevention strategies. The population-
based approach (-2 kg GWG in all individuals) led to decreased dispersion (measured by 
SD) of the birthweight distribution, which is favourable from a public health perspective. 
This is the opposite of the common criticism against Rose’s population approach and 
strengthens previous findings suggesting that it does not necessarily increase inequalities 
[52, 53].  
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6.1.2 Targeted interventions 
The population approach is usually set against a population-at-risk strategy that 
targets only individuals at high risk. Such a strategy can be successful if accurate risk 
assessment tools are available. Unfortunately, the prediction of fetal macrosomia is a 
difficult task, even with modern diagnostic tools, because of complex associations of 
environmental and genetic factors that determine fetal growth [54]. Our hypothetical high-
risk strategy targeted overweight and obese women, based on pre-pregnancy BMI, and 
promoted a more intensive reduction of GWG (-3 kg) compared with the population 
approach. Based on our calculation, the high-risk strategy underperformed the population 
approach in the prevention of macrosomia. This was due to a relatively high proportion of 
macrosomic infants, who were born to normal weight women. Our study population was 
relatively lean: 21% of participants were overweight or obese. The increase in low 
birthweight following the high-risk strategy was negligible, as expected. This approach of 
prevention may be more effective in more obese populations. 
6.1.3 Public health implications 
A recent study investigated the effect of GDM, BMI and GWG on the birthweight 
distribution using quantile regression [55]. The authors reported that individuals at higher 
risk of having a macrosomic infant (in the right tail of the birthweight distribution) are 
more vulnerable to changes in BMI and GWG. This finding is concerning if the obesity 
epidemic continues and may have even more adverse effects on future generations. The 
authors of the paper also called for further discussion how these results affect prevention 
stategies targeting individuals at high risk. From the aspect of prevention, we think that the 
heterogeneous effect of BMI and GWG on birthweight is in fact an opportunity to diminish 
the right tail of the birthweight distribution without increasing the number of low 
birthweight infants. Our results showed that a population approach promoting a more 
modest GWG in all women may offer greater benefits on a population-level, than a high-
risk approach in a relatively lean population. This notion highlights the clinical and public 
health importance of our findings, and the potentially detrimental consequences of using 
statistical methods that do not model sufficiently the complexity of associations. Our 
findings cannot be transferred in its original form to all risk factors, but show how quantile 
regression may help to define risk reduction strategies in the presence of complex 
associations between risk factors and outcomes. 
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6.1.4 Strengths and limitations 
We analysed the effect of BMI and GWG on birthweight with quantile regression, 
a method that gives a more complete picture of associations than classical regression 
models. Although, quantile regression was developed more than 30 years ago, its 
advantages have not been exploited in the field of epidemiology for a long time. Contrarily 
to the only recent study investigating the effect of maternal obesity, we had information on 
treatment received for diabetes during pregnancy, so this important factor, which could 
have biased previous results, was accounted for in our analysis. Another strength of the 
study was that BMI and GWG were kept as continuous variables to avoid loss of statistical 
power. 
The hypothetical prevention strategies were arbitrarily chosen and not optimised 
for the study population. We considered only changes in GWG and not in pre-pregnancy 
BMI, because in our opinion, although in many countries obese women wanting to be 
pregnant are adviced to lose weight, women who are already pregnant are more motivated 
to change their lifestyle habits, than the general population of women in childbearing age. 
In the high-risk strategy, the targeted group was selected based on BMI using a threshold 
value of 25 kg/m2. The efficacy of this strategy could be clearly improved with more 
complex risk assessment tools, but our aim was mainly to illustrate how quantile 
regression can help to estimate the effect of prevention strategies more accurately. The 
relatively healthy and lean study population came from a rather affluent area of Budapest, 
Hungary, so further investigation is necessary to replicate our results in other populations. 
Pregnancy outcomes, other than birthweight, should be also analysed in the future. 
6.2 Secular trends and age-related trajectories of risk factors 
We analysed secular trends and the natural progression of BMI, WC, SBP, DBP, 
TC, HDL with ageing by assessing age-related trajectories based on a large longitudinal 
dataset from the Whitehall II study (1985-2009). Distributional trends and age-related 
changes are discussed and compared with other studies. 
6.2.1 Obesity 
Recent results show that the global obesity epidemic is leveling off in younger 
generations, but increases are still observed among adult populations in Europe and Asia 
[56]. This highlights the importance of revealing determinants of trends from an 
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epidemiological aspect. General obesity trends are usually described by reporting mean 
BMI levels [4]. These results are easily interpreted, but give no information about the 
shape of distributions. Another usual approach is to report the prevalence of overweight 
and obesity [57–59]. This gives more, but still limited information on the higher segment 
of the BMI distribution. Studies focusing on entire distributions showed an increased right-
skewness in the US [19, 20, 60–62], Canada [63], China and in low- and middle-income 
countries [62, 64]. These studies were based on sequential cross-sectional analysis of 
distributions in different population-samples and mainly based on descriptive percentile 
statistics and to lesser extend on quantile regression [61]. This phenomenon that people 
who are already obese are more affected by the obesity epidemic was previously called and 
described as the “runaway weight gain train” [65]. The increasing BMI trend was more 
marked in men. This finding strengthens previous evidence showing that obesity levels in 
men are catching up with women [66–68]. One explanation might be a sex difference in 
the attitude to weight management [69]. Women usually set lower weight goals than men, 
who also have less attention on their ideal weight. 
We observed that while BMI did not increase in leaner groups, they still developed 
abdominal obesity indicated by a right-shift of the WC distribution’s lower segments. A 
possible explanation is that people lose muscle mass and simultaneously accumulate 
abdominal fat mass, because of more sedentary lifestyles. Our results are in line with 
findings in low- and middle-income countries showing a 2-4 cm increase of WC at a given 
level of BMI during a 18 years long period [70]. This notion is even more concerning in 
light of previous evidence from the InterAct study showing a strong association between 
abdominal obesity and glucose metabolism independently from general obesity [71]. A 
recent review highlights the importance of the assessment of WC in addition to BMI, 
because it gives independent information on obesity-related mortality [72]. Increasing 
abdominal obesity is a public health concern that affect both sexes similarly and calls for 
more attention on the development of prevention strategies. 
Our longitudinal trajectory analyses showed that younger generations experience a 
greater cumulative exposure to obesity. Participants born only 15 years later (in 1948 
versus 1933), reached overweight 10 and 6 years earlier in their life-course in men and 
women, respectively. We observed similar patterns in WC trajectories. The clinical 
importance of these results are emphasised by recent findings of the CARDIA study [73]. 
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The authors showed that a longer duration of general and abdominal obesity was linked to 
coronary heart disease in midlife. The association was independent of the degree of 
adiposity. This notion suggests that younger birth cohorts might be at a greater 
cardiometabolic risk and that prevention of obesity is of major importance already at an 
early age in the life-course. On the other hand, another study reported that reaching a 
healthy weight is not too late in adulthood [74]. Their prospective analyses showed that 
participants who were overweight or obese during childhood but not anymore in adulthood 
had similar risk of type 2 diabetes, dyslipidemia and atherosclerosis, compared with those 
who were never overweight or obese.  
Our analyses clearly showed that cohort effect should not be ignored when 
assessing age-related trajectories. While the oldest participants of the Whitehall II cohort 
grew up in the austerity of the 1930s, younger generations were born in the period of post-
war reconstruction, increasing welfare and food security. Recent results show that such 
effects still exists, as the height and weight of 6-year-old children increased in the last 30 
years and obesity prevalence continues to rise in less affluent populations [75]. Age-related 
changes cannot be analysed adequately based on cross-sectional data. A previous study 
reported that age-related increases in BMI might be underestimated in such analyses [76]. 
In addition, we argue that longitudinal analyses give biased estimates when cohort effects 
are ignored. Therefore we modelled cohort effects by adding year of birth (time-invariant 
variable) and its interaction with age to the models. The interaction term is responsible for 
the different curve characteristics (e.g. curvature and slope at a given age). Keeping age 
and year of birth as continuous variables is advisable to retain statistical power. 
6.2.2 Blood pressure 
Contrary to our observations in obesity measures, distributional trends in SBP were 
not consistent in one direction between phases. A marked decline was observed only 
between phase 7 and 9, especially in women. We cannot fully attribute this decline to a 
wider use of antihypertensive medication, because that increased already between earlier 
phases. In contrast, both our sequential cross-sectional and longitudinal analyses confirm a 
marked decline in DBP. The drop was similar along the entire distribution, which resulted 
a left-shift of the distribution. Regarding the age-related blood pressure trajectories, our 
results are in line with current understanding that SBP rises from mid to late adulthood 
(more rapidly among women), while DBP peaks around the age of 50 years and then starts 
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to decline, because of increasing aortic and small vessel stiffness [45, 77]. Compared to 
previous studies, our analyses accounted for secular trends and cohort effects that made it 
possible to observe different trajectory characteristics between birth cohorts. In addition to 
generally lower DBP levels, we also found that the decline started at a lower age in 
younger birth cohorts. As DBP is inversely associated with the risk of coronary heart 
disease after age 60, this notion imposes additional risk on younger birth cohorts [78]. The 
decreasing trends in SBP and especially in DBP have to be interpreted with caution. As 
DBP decreases with age while SBP increases, a widening gap develops between SBP and 
DBP that leads to an increasing pulse pressure, which is an independent determinant of the 
coronary heart disease [79]. In addition to an increase with ageing, pulse pressure has also 
increased with calendar year, leading to an additional risk of CVD due to a combined 
cohort and period effect. 
6.2.3 Cholesterol 
In contrast to previous studies, which reported trends based on mean levels, we 
analysed secular trends along the entire TC distribution. Our results showed a marked left-
shift of the entire distribution, which extends previous knowledge on decreasing trends [6, 
80, 81]. Although the observed decline may be partially due to the wider use of statins, 
especially in elderly, this cannot be the only cause, as values decreased in the left tail of the 
distribution too. This finding is in line with previous reports from developed countries 
emphasising the importance of positive changes in dietary patterns [46, 82]. They also 
argue that the marked decline started already before statins were introduced and further 
regulatory interventions are necessary to promote the use of healthier fats. Our analyses 
showed that the age-related trajectories of younger cohorts started to decline at younger 
ages in the life-course. It is likely because of decreasing thresholds above which lipid-
lowering treatment is prescribed. The effect of secular trends and cohort effects were so 
large during the last three decades that an unadjusted TC trajectory clearly underestimates 
true trajectories in late adulthood. This effect makes it a challenging task to isolate the 
effect of ageing from trends. Trends in HDL cholesterol are rarely investigated. Both of 
our models suggest favourable changes in HDL cholesterol levels in the last three decades. 
Although changes in HDL cholesterol were modest compared to TC. 
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6.2.4 Strengths and limitations 
When analysing secular trends, we did not only report mean levels of risk factors, 
but considered entire distribution characteristics. Quantile regression is a suitable tool for 
such analyses. Age-related trajectories were assessed based on a long period of observation 
(25 years) with up to five repeated measurements per person. Secular trends, cohort effects 
and ageing were considered simultaneously in our analyses. 
Handling missing data and attrition are important tasks when analysing longitudinal 
data. When the pattern of missingness is MAR, mixed-effects models give valid estimates 
for the age-related trajectories. To handle the case of MNAR, we conducted sensitivity 
analyses on a subgroup of individuals who participated up to phase 9. These analyses 
replicated our main findings, indicating that it is unlikely that loss to follow-up biased our 
age-trajectory estimates. When the follow-up period is long, standardisation of 
measurements is crucial and cannot be ignored. All laboratories participated in the 
National External Quality Assurance Scheme for TC and HDL cholesterol. Regarding 
blood pressure measures, it is unlikely that decreasing trends were due to changes in 
measurement device, because AOD used in the last two phases, produces slightly higher 
values than MRZ [83]. Our results were based on an occupational cohort study. Such 
cohorts are usually healthier than the general population. Previous studies from the 
Whitehall II study showed lower mortality rates [84], lower SBP trajectories, but similar 
BMI trajectories compared with population-based cohorts [45]. Another limitation of our 
sequential cross-sectional analysis, was that we could analyse only the 57-61 age group. 
Further research is necessary to confirm our results on a population level. 
6.3 Diurnal variation of glucose measures 
6.3.1 Diabetes diagnosis 
Diurnal variation of glucose tolerance has not received much attention in the past 
decades, even though the definition of diabetes has been based on fasting and/or 2-hour 
post-OGTT values since 1965. After the recent introduction of HbA1c as an additional 
diagnostic criterion, analyses investigating the overlap between HbA1c and OGTT based 
diabetes diagnosis have implicitly assumed the OGTT to be a type of gold standard. 
Previous studies also showed a significant intra-individual variation of glucose measures. 
This result had important clinical implications: approximately 20% of patients who 
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received a diagnosis based on an OGTT, would not have a diagnosis when retested [85]. 
Our analysis, based on a large sample of repeated measures in a well characterised cohort, 
shows that even a few hours difference in fasting duration or sampling time can affect 
whether or not somebody is diagnosed as having diabetes based on an OGTT. 
6.3.2 Fasting glucose 
The observed decline in FPG levels during the day is in line with previous findings, 
which also showed clinically relevant differences between morning and early afternoon 
FPG measures [28]. Our findings support the notion that standardisation of fasting duration 
and time of day is an important point in the protocols of epidemiological studies [29]. 
Glucose measures even from fasting subjects are not necessarily unbiased, so adjustment 
for timing factors is advisable if data are available. These results indicate that timing 
should not be ignored when diagnosing diabetes, or comparing individual glucose levels 
longitudinally in clinical practice. Our results are also consistent with previous findings on 
the modest role of fasting duration in addition to time of day [30]. We agree with the 
authors conclusions that more effort on the standardisation or assessment of other factors, 
like diet and physical activity, is necessary. 
6.3.3 Glucose tolerance (2hPG) 
Our results are consistent with previous evidence, indicating higher 2hPG levels in 
the afternoon than in the morning [25–27]. We also confirmed the notion that diurnal 
variation in glucose tolerance increases with age. However, we found no clear evidence to 
suggest that obesity would reduce diurnal variation in 2hPG [26]. A previous review 
reported that there is no evidence for an effect of fasting duration in addition to time of day 
[86]. In contrast, fasting duration improved our models for 2hPG even if time of day was 
accounted for. This difference might be because of the lack of statistical power or different 
protocols regarding fasting duration in previous studies. Although the studies are not 
directly comparable, our results support the recent finding of an underestimation of glucose 
tolerance among pregnant women who had an afternoon rather than a morning 1-hour, 
50 g, non-fasting glucose challenge test, as compared to a confirmatory morning 3-hour, 
100 g fasting OGTT performed on a separate day [87]. 
6.3.4 HbA1c 
HbA1c reflects blood glucose concentrations retrospectively in the previous 2-3 
months. As a result of a WHO expert consultation in 2009, it was recently accepted as a 
	   40 
new diagnostic tool for diabetes. A recent study reported that HbA1c is not only useful to 
predict future diagnosis of diabetes, but had an even stronger association with the risk of 
CVD and death from all cause mortality than FPG [88]. Similarly stronger associations 
were found between HbA1c and ischaemic heart disease in a large Danish population [89]. 
In addition to these findings, one of the most important features of an HbA1c test remains 
the independence of results from time of day and fasting duration. We confirmed this 
notion in a large occupational cohort study. 
6.3.5 Strengths and limitations 
The key strength of our study was that we did not categorise time of day and 
fasting duration. This was possible because of the detailed assessment of variables. 
Another strength of our study was, that we analysed all three measures parallel in the same 
population. However, the relatively low proportion of women in the study resulted in wider 
confidence intervals for their coefficient estimates. The longitudinal structure of the dataset 
was neither an advantage nor a disadvantage, because it was handled according to common 
practice by adding random effects to the models and adjusting them for study phase. Our 
analyses were based on data from an occupational cohort, that is known to be relatively 
healthier than the general population. Further research is needed to examine the 
generalisability of our findings to other populations, ethnic groups and pregnant women. 
	   41 
7 SUMMARY AND CONCLUSIONS 
Maternal obesity and GWG are targets for prevention of adverse pregnancy 
outcomes related to birthweight. Using quantile regression, we found that GWG was 
positively associated with infant birthweight, however in leaner women its effect was 
heterogeneous along the distribution of birthweight and increased towards higher 
percentiles. Classical regression models cannot reveal such differences and give a rather 
incomplete picture of associations. We also evaluated the effect of hypothetical prevention 
strategies on the birthweight distribution. We concluded that a population-wide lowering 
of GWG would not lead to a uniform left-shift of the birthweight distribution, but that the 
right tail would be more affected and the total variance would decrease. Our findings 
support the promotion of strategies to lower GWG on a population-level. These results 
indirectly imply that current GWG guidelines might be too permissive. We also conclude 
that quantile regression is a useful tool for epidemiologists and public health practitioners 
to investigate complex, distributional associations of risk factors and outcomes. 
The past 25 years brought marked changes in cardiometabolic risk factors. Younger 
generations were more obese, than their older peers at any given age. Contrarily,  we 
observed a more favourable lipid profile (i.e. lower TC levels and higher HDL cholesterol 
levels) in younger cohorts. Furthermore, the observed secular trends affected the shape of 
risk factor distributions. Whereas the increase in obesity led to more right-skewness, the 
decreases in TC and interestingly in DBP were characterised by a left-shift of the entire 
distributions. These results show that the last three decades brought strong and 
heterogeneous secular trends in obesity, blood pressure and lipid levels. Decreasing CVD 
mortality in the UK suggest that the negative trends in obesity are counterbalanced by 
favourable changes in other risk factors. The disparity of these trends indicate that the 
relative importance of these risk factors is likely to change over time. This observation has 
potential implications for the way we assess global CVD risk based on risk scores, 
highlighting the need to reassess the calibration of component weights on a regular basis. 
Our findings also suggest that more detailed models of risk factor progression may be 
needed to help track the development not only of mean levels but also changing risk factor 
distributions in the population. Secular trends caused by period and cohort effects should 
be considered in longitudinal analyses of age-related risk factor trajectories to avoid biased 
estimates.  
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The diagnosis of diabetes is based on blood glucose levels, therefore the 
investigation of factors influencing glucose levels on a population level is an important 
task from an epidemiological perspective. Based on a large sample, we showed that time of 
blood sampling and duration of fasting prior to blood sampling affect FPG and 2hPG 
levels considerably. As expected, neither of these factors affected HbA1c. Furthermore we 
showed how age and BMI affect the diurnal variation of glucose tolerance and fasting 
glucose measures. These results highlight the importance of standardising the diagnostic 
OGTT regarding time of day and fasting duration that is often overlooked in clinical 
practice and in epidemiological investigations. FPG and 2hPG measures vary by different 
fasting duration periods even after 8 hours of fasting, independently of time of blood 
sampling. This finding suggests that the current WHO recommendation may not be strict 
enough regarding time of blood sampling and fasting duration and adjustment for these 
factors is necessary in clinical practice and epidemiological studies. 
Epidemiology provides the scientific basis for public health practice by exploring 
the “occurrence and distribution of health-related states or events in specified populations, 
including the study of the determinants influencing such states, and the application of this 
knowledge to control the health problems” [90]. Our studies demonstrated that the use of 
appropriate statistical methods is crucial when exploring the relative importance of risk 
factors and their associations with health-related outcomes, identifying subgroups at risk 
and evaluating the effectiveness of prevention strategies. With the knowledge gathered in 
developed countries, where CVD incidence already seems to be declining, a huge burden 
of disease can hopefully be prevented in developing countries which are going through 
similar economical and societal changes to those that were already seen in high-income 
regions. Adequate control of modifiable risk factors is a key tool to achieve this goal. 
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Novelties and key messages 
Maternal obesity and gestational weight gain 
• We demonstrated the rarely exploited potential of quantile regression in public 
health and preventive medicine. 
• The association between gestational weight gain and birthweight was altered by 
BMI and was heterogeneous in leaner women. 
• Based on a statistical model, we found that a population-based intervention 
promoting a more modest gestational weight gain might offer more favourable 
changes in the birthweight distribution, than a high-risk approach. 
Secular trends and age-related trajectories of risk factors 
• Trends of cardiometabolic risk factors were described using sophisticated 
statistical methods focusing on entire distribution characteristics and not only on 
mean levels. 
• The obesity epidemic affected those already overweight and obese, which led to 
increasing dispersion and right-skewness of distributions. 
• The marked drop in diastolic blood pressure has to be interpreted with caution, 
because of its negative effects in elderly and the increasing pulse pressure. 
• Secular trends were strong and heterogeneous in the last decades and therefore 
should be taken into account when analysing age-related trajectories to avoid 
biased estimates caused by large differences between successive birth cohorts. 
Diurnal variation of glucose measures 
• We investigated the combined effect of time of day and fasting duration on all 
three glucose measures, based on a large sample. 
• We gave estimates for the magnitude of diurnal variation by keeping time of day 
and fasting duration as continuous variables. 
• Time of blood sampling and fasting duration have clinically relevant effects on 
glucose measures even if WHO recommendations are followed. 
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